The Board Members at Cajal Neuroscience provide strategic oversight, governance, and high-level decision-making to guide the company's focus on drug discovery for neurodegenerative diseases. They influence key business directions, ensure financial sustainability, and support the executive leadership team in achieving long-term objectives.
View all